Burcon NutraScience (STU:BNE) EBIT : €-15.95 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Burcon NutraScience EBIT?

Burcon NutraScience's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2023 was €-1.24 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was €-15.95 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Burcon NutraScience's annualized ROC % for the quarter that ended in Jun. 2023 was -89.41%. Burcon NutraScience's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -744.62%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Burcon NutraScience's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -65.16%.

Burcon NutraScience EBIT Historical Data

The historical data trend for Burcon NutraScience's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burcon NutraScience EBIT Chart

Burcon NutraScience Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT

Get a 7-Day Free Trial

-2.95

-2.62

0.10

-7.31

-17.00

Burcon NutraScience Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EBIT	Get a 7-Day Free Trial															-2.92	-2.42	-11.15	-1.14	-1.24

Competitive Comparison of Burcon NutraScience's EBIT

For the Packaged Foods subindustry, Burcon NutraScience's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burcon NutraScience's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Burcon NutraScience's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Burcon NutraScience's EV-to-EBIT falls into.

Burcon NutraScience EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-15.95 Mil.

Burcon NutraScience (STU:BNE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Burcon NutraScience's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	-4.928 * ( 1 - 0% )	/	( (5.508	+	5.515)	/ 2 )
=	-4.928	/	5.5115
=	-89.41 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6.757	-	0.403	-	( 0.995	-	max(0, 0.427	-	1.273	+	0.995	))
=	5.508

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8.168	-	0.47	-	( 2.482	-	max(0, 0.503	-	2.686	+	2.482	))
=	5.515

Note: The Operating Income data used here is four times the quarterly (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Burcon NutraScience's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-4.948	/	( ( (0.672 + max(-0.126, 0))	+	(0.657 + max(-0.266, 0)) )	/	2 )
=	-4.948	/	( ( 0.672	+	0.657 )	/	2 )
=	-4.948	/	0.6645
=	-744.62 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.227	+	0	+	0.051)	-	(0.403	+	0	+	0.00099999999999995)
=	-0.126

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.117	+	0	+	0.087)	-	(0.47	+	0	+	0)
=	-0.266

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Burcon NutraScience's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	-15.951	/	24.479
	=	-65.16 %

Burcon NutraScience EBIT Related Terms

Thank you for viewing the detailed overview of Burcon NutraScience's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Burcon NutraScience (STU:BNE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Burcon NutraScience Corp (STU:BNE) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

BRCNF:USA BNE:Germany BU:Canada

Address

1946 West Broadway, Vancouver, BC, CAN, V6J 1Z2

Website

https://www.burcon.ca

Burcon NutraScience Corp is a technology company in the development of plant-based proteins. With over 290 issued patent applications, that have been developed, Burcon has grown a portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed, and more. Its joint venture Merit Foods is building a protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients.